Healthcare Distribution Alliance – Patients Move Us.

+ About
- Role of Distributors
- Membership
- HDA History
- Member Directory
- Staff Directory
- Industry Recognition
- Executive Committee
- Mission and Values
- Board of Directors
- Join HDA
- Councils and Committees
- Careers
- About
  
  Information regarding HDA's history, leadership, mission, values and staff.
+ Issues
- Pharmaceutical Traceability
- Distributor Licensure
- Importation of Prescription Medicines
- Drug Shortages
- Prescription Drug Abuse and Diversion
- Emergency Preparedness
- Taxes
- Grassroots Advocacy
- Reimbursement
- Issues
  
  HDA reviews key priority issues and advocates on behalf of its pharmaceutical distributor members for standards, public policies and business processes that ensure a safe and efficient supply chain.
+ Events
- Distribution Management Conference and Expo
- Webinars
- Business and Leadership Conference
- Speaker Resource Center
- Traceability Seminar
- Image Gallery
- PCSC Educational Seminar
- Events
  
  HDA regularly brings members and key healthcare supply chain stakeholders together to share industry information, learn about best practices, and be introduced to new products and services.
+ News
- Press Releases
- Blog
- Testimony
- HDA in the News
  
  Press releases, public testimony executive statements and information on HDA's efforts on behalf of pharmaceutical distributors and the supply chain.
+ Resources
- Publications
- Allied Against Opioid Abuse
- Vital Link Toolkit
- HDA Origin
- Webinars
- PCSC
- Resources
  
  HDA and the HDA Research Foundation produce a variety of resources to enhance the value of the supply chain and increase industry knowledge.

Share Print

Home | News | HDA Blog | Archives

HDA Blog

January 2019 Archives

HDA Featured in Chain Drug Review's 2019 "Pharmacy Outlook"

Posted 01/07/2019

With a new year in full swing, HDA President and CEO John M. Gray looked ahead to the organization’s 2019 priorities (along with other industry association executives) as part of the Chain Drug Review “Pharmacy Outlook” feature.